A new prototype for motion sickness medication has surfaced—a creation and design by researchers at the RoshaDarou Co—which may offer some innate advantages over capsule form drugs that have slower absorption rates and that have less patient compliance. The newest solution being considered: medicated chewing gum. The solution is being developed to enhance the absorption rate and increase patient usage (a lot of patients don’t adhere to doctor advice on motion sickness drugs, and as a result do not reap the benefits of the slower acting capsule forms of these medications). Could this revelation present a new direction for all drugs?
Tuesday, October 23, 2012
New Medicated Chewing Gum Could Help Prevent Motion Sickness
